Plexus Corp. shares are up about 3.11% to $223.56 in Thursday trading (April 9, 2026) amid an earnings setup trade rather than a single, clearly identifiable company-specific headline. With the next quarterly report approaching later this month, incremental buying has been flowing into names with improving FY2026 narratives, and Plexus has been framed around new program ramps and sequential growth expectations coming out of its most recent earnings update.

The latest company update in circulation is Plexus’ fiscal first-quarter 2026 results and outlook, which highlighted expectations for accelerating sequential revenue growth in fiscal Q2 driven by new program ramps, market-share gains, and improved end-market demand. Traders often revisit these points heading into the next print, particularly when the stock is already trending higher and expectations are being reset into the upcoming report. (pr.comtex.com)

On the sell-side, Benchmark reiterated a Buy rating on March 16, 2026, keeping a positive tone on the name into FY2026. Separately, Benchmark raised its price target earlier in 2026 ahead of earnings, reinforcing the idea that the bull case is tied to execution and growth translating into sustained margins. (benzinga.com)

The next key catalyst is the company’s upcoming quarterly earnings report (commonly tracked for late April based on prior reporting cadence). With the stock trading near recent highs, the market’s reaction is likely to hinge on whether revenue growth is visibly accelerating, how margins track versus expectations, and whether guidance supports the ramp narrative that has underpinned the FY2026 setup. (marketbeat.com)